Status:
COMPLETED
Next Generation " Pre-clinical Model for Colorectal Cancer Metastases and Hepatocellular Carcinomas
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Colorectal Cancer Metastases and Hepatocellular Carcinomas
Eligibility:
All Genders
18+ years
Brief Summary
Recently, oncology has moved to a new clinical practice, more personalized, called Predictive Oncology (PO). PO comes from our knowledge about tumor heterogeneity that implies that each disease, thus...
Detailed Description
Recently, oncology has moved to a new clinical practice, more personalized, called Predictive Oncology (PO). PO comes from our knowledge about tumor heterogeneity that implies that each disease, thus...
Eligibility Criteria
Inclusion
- \> 18 yo
- Patient with a diagnosis of hepatocellular carcinomas or colorectal cancer metastases
- Patient affiliated to the national healthcare program " sécurité sociale "
- Patient who has been informed and agreed to the proposed research program
Exclusion
- Patients with more than one malignancy
- Patients receiving sustained immunosupressive treatments
- Patient with severe infection
- Patient under legal supervision, in situation of emergency or not able to express its consent
Key Trial Info
Start Date :
June 6 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05384184
Start Date
June 6 2019
End Date
June 30 2023
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ap-HM hopital nord
Marseille, France, 13915